3. GOLD Executive Committee.Global Strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease (Revised 2011).[EB/OL][2015-09-16].http://www.goldcopd.org.
[4]
4. Charlson M,Pompei P,Ales K,et al.A new method of classifying prognostic comorbidity in longitudinal studies:development and validation.J Chronic Dis,1987,40:373-383.
9. Schneeweiss S,Wang PS,Avorn J,et al.Improved comorbidity adjustment for predicting mortality in Medicare populations.Health Serv Res,2003,38:1103-1120.
[7]
10. Groenewegen KH,Schols AM,Wouters EF.Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.Chest,2003,124:459-467.
[8]
6. Sachdev M,Sun JL,Tsiatis AA,et al.The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease.J Am Coll Cardiol,2004,43:576-582.
[9]
7. Goldstein LB,Samsa GP,Matchar DB,et al.Charlson index comorbidity adjustment for ischemic stroke outcome studies.Stroke,2004,35:1941-1945.
[10]
8. Fried L,Bernardini J,Piraino B.Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients.Am J Kidney Dis,2001,37:337-342.
